Firms fill antiretroviral gap in South Africa.
Venter
Lester
L
The Lancet, London NW1 7BY, UK. lester.venter@btopenworld.com
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology; D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D009786:Occupational Health Services; D015995:Prevalence; D013019:South Africa / Q000453:epidemiology
D044966:Anti-Retroviral Agents